|
The document is a final report on a mutagenicity test of a substance identified as T-6357, conducted by Corning Hazleton Inc. for 3M, using an in vivo mouse micronucleus assay to assess potential genetic toxicity.
|
1996 |
AR226-0233
|
zn7rzZkGaQgDV8rLBvo4Qyp0 |
27 |
|
The document is a final report of a mutagenicity test on T-6294 conducted by Corning Hazleton Inc. for 3M, using an in vivo mouse micronucleus assay to assess the potential mutagenic effects of the substance.
|
1996 |
AR226-0239
|
7ORDyg4OaV8nn6NdbeLMerRoe |
36 |
|
The document is a final report of a mutagenicity test on PFOA conducted by Corning Hazleton Inc. for 3M, detailing compliance with Good Laboratory Practice regulations and quality assurance inspections.
|
1996 |
AR226-0252
|
Nez6m3xmkpNOnrkLnvaD3Q5ow |
37 |
|
The document is a final report of a mutagenicity test on T-6295 conducted by Coming Hazleton Inc. for 3M, using an in vivo mouse micronucleus assay to evaluate the potential mutagenic effects of the substance.
|
1996 |
AR226-0130
|
a5bwq1ErY2az1OJ0m3O1aZQX |
39 |
|
The document reports on a biodegradation test of a mixture containing perfluorooctanesulfonate (PFOS) conducted by Pace Analytical Services for 3M Company, revealing high Chemical Oxygen Demand (COD) and Biochemical Oxygen Demand (BOD) values, but lacks detailed methodology and characterization of the sample.
|
1996 |
AR226-0692
|
qkRmdRJp0DrR4gpGd2EyBrBdK |
7 |
|
The document is a final report from Hita Research Laboratories on a bacterial reverse mutation test of a substance referred to as T-1, sponsored by Sumitomo 3M Limited, conducted in compliance with Japanese toxicity investigation standards.
|
1996 |
AR226-0136
|
4aEJgykrQLBD4k4ZG8x69m3NQ |
29 |
|
The document reports on a biodegradation test of a mixture containing perfluorooctanesulfonate (PFOS) produced by 3M, indicating high Chemical Oxygen Demand (COD) and Biochemical Oxygen Demand (BOD) values, but lacks reliable conclusions due to insufficient method description and characterization of the inoculum.
|
1996 |
AR226-0848
|
dQ3me8JQemE30JO7x8k7XL7Zb |
9 |
|
The document reports on an acute toxicity study of a mixture containing perfluorooctanesulfonate (PFOS) conducted on juvenile golden orfe fish, revealing a 96-hour LC50 value of 58 mL/L.
|
1996 |
AR226-0849
|
qdy4j0aBV3g3oqLO3892z4OJM |
10 |
|
The document reports on an acute toxicity study of a mixture containing perfluorooctanesulfonate (PFOS) tested on Daphnia magna, revealing a 24-hour EC50 value of 64 mL/L for the mixture.
|
1996 |
AR226-0851
|
YDRyLJYyx3wgpgdLwwkKJM23D |
10 |
|
The document reports on a TTC test conducted by 3M Company on a mixture containing 1.30% PFOS, indicating that exposure concentrations between 0.1 and 10 mL/L showed results comparable to the blank control, but the study lacks detailed descriptions and data quality is rated as Klimisch ranking 3.
|
1996 |
AR226-0852
|
Rjw5MwKD0b5262X9jajMrmRX |
10 |
|
The document reports on an Activated Sludge Respiration Inhibition Test (MITI Test) conducted on a mixture containing 1.30% PFOS, revealing a 28-day biological oxygen demand of 82.5%.
|
1996 |
AR226-0853
|
RaMaw1RRvrnL0jaxmBNgNy4mE |
10 |
|
The document details a Microbics Microtox toxicity test conducted on a mixture containing perfluorooctanesulfonate (PFOS) as part of the test substance FC-603EF, indicating that the data may not accurately reflect the toxicity of the fluorochemical component due to incompletely characterized concentrations of impurities.
|
1996 |
AR226-0854
|
Mob49Qak54V8GjoX55VMxDDxz |
9 |
|
The document describes an activated sludge respiration inhibition test conducted on a mixture containing 1.30% PFOS, assessing its acute toxicity using OECD Guideline 209, with results indicating potential inaccuracies due to the presence of impurities.
|
1996 |
AR226-0855
|
gNNpzOLkOey1zN3O6w5229DJ |
10 |
|
This document details an acute toxicity test of a PFOS-containing mixture (FC-603EF) on Daphnia magna, conducted under OECD Guideline 202, with findings indicating the need for careful interpretation due to the presence of impurities in the test sample.
|
1996 |
AR226-0856
|
RqBaBOj9Mgp12gKDepMxEOvV |
10 |
|
The document details a toxicity test conducted on a mixture containing 1.30% perfluorooctanesulfonate (PFOS) using the OECD Guideline 201 method to assess its impact on the growth of the aquatic plant species Selenastrum capricornutum over a 96-hour exposure period.
|
1996 |
AR226-0857
|
2jQyZbpKZzG19x8ye6KoZpMa6 |
12 |
|
The document is a quality assurance statement for a chromosomal aberration study of Sample D-1 conducted by Mitsubishi Chemical Safety Institute Ltd. for Sumitomo 3M Limited, adhering to GLP standards.
|
1996 |
AR226-0308
|
06Ew28g9dka4JrGrevxLOEnQx |
17 |
|
The document reports on a biodegradation test of a mixture containing perfluorooctanesulfonate (PFOS) produced by 3M Company, indicating high Chemical Oxygen Demand (COD) values but noting that the sample's purity was not properly characterized, which may affect the accuracy of the biodegradation potential assessment.
|
1996 |
AR226-0890
|
v6LDZjxzVpKdQ6momeD2Yeqrb |
6 |
|
The document reports on a toxicity test of a PFOS-containing mixture (FC-3017) on the aquatic plant species Selenastrum capricornutum, indicating that the study followed OECD guidelines but lacked detailed data on the toxicity results due to incomplete characterization of the test substance.
|
1996 |
AR226-0895
|
n9VkrjOqa2qmBj28wvYpJJGp1 |
7 |
|
This analytical report by Advanced Bioanalytical Services investigates the in vitro metabolism of compounds T-6292, T-6293, T-6294, and T-6295 using rat and human hepatocytes with advanced LC/MS techniques, prepared for the 3M Medical Department.
|
1996 |
AR226-0328
|
0qzOEwo74V77Kd4kqgw23LJZO |
45 |
|
The document reports on a study of 51 employees with the highest blood levels of C-8 (perfluorooctanoic acid), indicating minimal evidence of disease attributable to C-8, with some elevations in liver enzymes and a few cases of kidney disease, but no definitive conclusions due to lack of controlled studies.
|
1996 |
AR226-1307
|
jyvkNYO19w9nq8qn87EMMQ2B2 |
6 |
|
The document is a final report on a mutagenicity test of T-6564 conducted by Coming Hazleton Inc. for 3M Corporation, using an in vivo mouse micronucleus assay to assess the potential mutagenic effects of the substance.
|
1996 |
AR226-0430
|
By070g964dLojDb7rvqJ5rggj |
26 |
|
The document is a final report on a mutagenicity test conducted by Corning Hazleton for 3M Corporation, measuring chromosomal aberrations in Chinese hamster ovary (CHO) cells using the substance T-6564, with findings compliant with Good Laboratory Practice regulations.
|
1996 |
AR226-0431
|
x5bLLy8ROq22yo142VX4LxGeb |
30 |
|
The document is a final report of a mutagenicity test conducted by Coming Hazleton Inc. for 3M Corporation, assessing the mutagenic potential of a substance identified as T-6564 using the Salmonella - Escherichia coli/mammalian-microsome reverse mutation assay, with findings indicating compliance with Good Laboratory Practice regulations.
|
1996 |
AR226-0432
|
kVOdo9mBNQdJrGNnoR1Q2x7J |
34 |
|
The document is a final report on a mutagenicity test conducted by Corning Hazleton for 3M Corporation, measuring chromosome aberrations in human whole blood lymphocytes related to the substance T-6342.
|
1996 |
AR226-0433
|
MoGE6nEoexgJEVzr7g3kezZ4k |
29 |
|
The document is a final report on a mutagenicity test conducted by Corning Hazleton for 3M Corporation, assessing chromosomal aberrations in Chinese hamster ovary (CHO) cells related to the substance T-6342.
|
1996 |
AR226-0434
|
kmBvpgbYdkb0LbLwox5yN9nDb |
35 |
|
This letter from the Robert A. Taft Laboratories addresses a Health Hazard Evaluation regarding employee exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) at the 3M Corporation in Cottage Grove, Minnesota, noting that no health effects were observed despite concerns over elevated blood fluoride levels and the implementation of engineering controls and personal
|
1996 |
AR226-1350
|
G639E4gvM3ByqzdxGqQxomY6q |
6 |
|
The document discusses a study by Gilliland and Mandel published in the American Journal of Industrial Medicine, which evaluates the effects of serum perfluorooctanoic acid (PFOA) on hepatic enzymes, lipoproteins, and cholesterol in 115 occupationally exposed workers, finding no significant clinical hepatic toxicity at the measured PFOA levels, although it suggests PFOA may exacerbate obesity
|
1996 |
AR226-0475
|
YKrppk55rVoVDJGN8d1Jve80 |
8 |
|
The document reports the results of a Microbios Microtox toxicity test conducted on perfluorooctanoic acid, ammonium salt (PFOA ammonium salt), indicating that the 30-minute EC50 value was 730 mg/L, suggesting low acute toxicity to the test organism Photobacterium phosphoreum.
|
1996 |
AR226-0521
|
LpOZobN0vED3BQ4q5gYbEbxqz |
6 |
|
The document reports the results of a Microbios Microtox toxicity test on perfluorooctanoic acid, ammonium salt (PFOA ammonium salt), indicating an EC50 value of 4460 mg/L at 5 minutes and 3360 mg/L at 15 minutes, although the test sample's purity was not sufficiently characterized.
|
1996 |
AR226-0522
|
VG1mbwXZeOgJwgzJxYBqyZ5mN |
8 |
|
The document details a Microtox toxicity test conducted on a mixture containing perfluorooctanoic acid, ammonium salt (PFOA ammonium salt), specifically the test sample FC-1015-X, to evaluate its toxicity using Photobacterium phosphoreum, although the purity of the sample was not sufficiently characterized.
|
1996 |
AR226-0523
|
zzqo96p9wBqkzye1Y6Z94za30 |
6 |
|
The document describes an activated sludge respiration inhibition test conducted on perfluorooctanoic acid (PFOA) ammonium salt, specifically the FC-1015-X sample, to assess its toxicity compared to a reference substance, 3,5-dichlorophenol, using activated sludge from a wastewater treatment plant.
|
1996 |
AR226-0524
|
GmOYDNaxqnEvpgbm8pmOQ6NQm |
9 |
|
The document reports on a toxicity test of perfluorooctanoic acid, ammonium salt (PFOA ammonium salt), specifically examining its effects on the aquatic plant species Selenastrum capricornutum using a mixture from the 3M product FC-1015, with findings indicating potential toxicity but noting that the purity and characterization of the test sample were incomplete.
|
1996 |
AR226-0526
|
Yj4oEGwoD2YQVp43wJV4J4e2E |
23 |
|
The document details an acute toxicity test of perfluorooctanoic acid, ammonium salt (PFOA ammonium salt), specifically the FC-1015 sample, on Daphnia magna, conducted under USEPA guidelines, with findings indicating that the toxicity data may not accurately reflect the test substance due to impurities in the sample.
|
1996 |
AR226-0527
|
EvbvnxwZxmKy8DKwDg7R82wzx |
28 |
|
The document details an acute toxicity test of perfluorooctylsulfonate (PFOS) conducted on the fish species Pimephales promelas, using a test sample from 3M, with specific conditions and methods outlined for the 96-hour exposure period.
|
1996 |
AR226-0534
|
oDbVjVDG5NOVa89JXMVrykx5X |
11 |
|
The document details an acute toxicity test of perfluorooctylsulfonate (PFOS) on the aquatic invertebrate Daphnia magna, conducted by 3M in 1996, using a mixture of the test substance in water, with monitoring of various environmental parameters.
|
1996 |
AR226-0535
|
gEgVDwdDjo010Q4GDQyoJxDRQ |
11 |
|
The document details a Microtox toxicity test conducted on a mixture containing perfluorooctylsulfonate (CAS # 251099-16-8) produced by 3M, indicating that the test sample was a 2-phase dispersion and involved Vibrio fischeri as the test organism, although no adjustments were made for the actual concentration of the test substance.
|
1996 |
AR226-0538
|
KG3DQD4NKXBXdBqK8p2KxNmex |
7 |
|
The document discusses a meeting scheduled for December 6, 1996, involving Rik Brandenburg and representatives from Hoechst and ICI to collaborate on analytical methods for determining the migration of C-8 (PFOA) from PTFE-coated pans into food simulants, addressing challenges in measuring migration into olive oil.
|
1996 |
AR226-1665
|
71wwRM6O7EGoD75eV5Eomdba8 |
1 |
|
The document reports on a biodegradation test for a mixture containing perfluorooctanesulfonate (PFOS) conducted by MDS Environmental Services for 3M Canada, revealing high Chemical Oxygen Demand (COD) and Biochemical Oxygen Demand (BOD) values, but lacking conclusive results due to insufficient characterization of the sample and methodology.
|
1995 |
AR226-0691
|
qdapL4BLeep4rdYy09nyXwEKk |
3 |
|
This document details an acute toxicity test of a PFOS-containing mixture (FC-201AF) on fathead minnows (Pimephales promelas) conducted according to OECD Guideline 203, with findings indicating the need for caution due to the presence of impurities in the test sample.
|
1995 |
AR226-0693
|
vVzJ1pjrBJDy8voz769qrvxq8 |
7 |
|
The document details a toxicity test conducted on a mixture containing perfluorooctanesulfonate (PFOS) using the freshwater algae species Selenastrum capricomutum, following OECD guidelines, although the study's results and specific conditions are inadequately characterized.
|
1995 |
AR226-0694
|
X71yvpzXKzOdDk814rXaJj4B |
6 |
|
The document reports on an acute toxicity test of a mixture containing perfluorooctanesulfonate (PFOS) on the aquatic invertebrate Daphnia magna, indicating that the test sample, FC-201AF, includes 3% PFOS among other components, but notes that the data may not accurately reflect the toxicity of the fluorochemical due to incomplete characterization of impurities.
|
1995 |
AR226-0698
|
4abOMo0E8zvpy6a8rNz2ajJrV |
3 |
|
The document reports on a Microbios Microtox toxicity test conducted on a mixture containing 3% PFOS, revealing a 5-minute EC50 value of 154 mg/L for the test organism Photobacterium phosphoreum.
|
1995 |
AR226-0699
|
v61JKKRBnpLaV5kY8JqKvVZjq |
7 |
|
The document describes an Activated Sludge Respiration Inhibition Test conducted on a mixture containing 3% perfluorooctanesulfonate (PFOS) and various other components, indicating that the data may not accurately reflect the toxicity of the fluorochemical due to incompletely characterized concentrations of impurities.
|
1995 |
AR226-0700
|
O6rx0VMMrmJVabp57aaZNJ3X |
10 |
|
The document outlines a study conducted by 3M Medical Department Toxicology Services to determine the metabolism of test articles T-6292, T-6293, T-6294, and T-6295 using isolated rat and human hepatocytes, with the aim of generating data for regulatory applications related to FDA permits.
|
1995 |
AR226-0162
|
1Q98BpDOEw1Y238E889MZjrxa |
10 |
|
The document details a nitrification inhibition test conducted on a mixture containing perfluorooctanesulfonate (PFOS) and other components, indicating that the test was performed using activated sludge from a wastewater treatment plant to assess the impact of PFOS on microbial nitrification.
|
1995 |
AR226-0765
|
bBqgb20qEdvbDBVvDVJ41rk13 |
8 |
|
The document reports on a nitrification inhibition test conducted on a mixture containing perfluorooctanesulfonate (PFOS) produced by 3M, indicating that the EC50 for the test substance was greater than 498 mg/L, suggesting low toxicity to nitrifying microorganisms.
|
1995 |
AR226-0766
|
rpdXG9GRmjB6YKwXekRZea6vG |
6 |
|
The document details an acute toxicity test conducted on fathead minnows (Pimephales promelas) using a mixture containing 1% PFOS, revealing that the test was performed under standard guidelines without GLP compliance, and highlights the test conditions and methodology used to determine toxicity levels.
|
1995 |
AR226-0767
|
zQzwE6L3YOgQ3kwBxNkbGzYQm |
9 |
|
The document reports on a blood testing program conducted in June 1995 at the Antwerp plant to measure individual exposures to PFOS and PFOA, comparing exposure levels among participants and with other fluorochemical manufacturing facilities while analyzing various health parameters.
|
1995 |
AR226-0175
|
reJ21b8KegmwnrapG0BgNb2oG |
15 |
|
The document details a toxicity study of a mixture containing 0.5% PFOS, conducted according to OECD guidelines, assessing its effects on the growth of the freshwater algae species Selenastrum capricomutum over a 96-hour exposure period.
|
1995 |
AR226-0864
|
bBG253KR2KBRzeZ27gzxk6x7y |
6 |
|
The document details a Microbios Microtox toxicity test conducted on a mixture containing 0.67% PFOS, identifying its composition and noting that the data may not accurately reflect the toxicity of the fluorochemical component due to incomplete characterization of impurities.
|
1995 |
AR226-0891
|
3eBbq80BaQ68Nkx9bvd03Qm3J |
12 |
|
The document details an acute toxicity test conducted on fathead minnows (Pimephales promelas) using a mixture containing 0.67% perfluorooctanesulfonate (PFOS) as part of the test substance FC-3017, with exposure concentrations ranging from 1.0 to 1000 mg/L over a 96-hour period.
|
1995 |
AR226-0892
|
10Nv7k4Y6KxapzygqemQDQxBq |
7 |
|
The document details an activated sludge respiration inhibition test conducted on a mixture containing perfluorooctanesulfonate (PFOS) as part of FC-3017, indicating that the test was performed to evaluate the toxicity of the fluorochemical component using OECD Guideline 209.
|
1995 |
AR226-0893
|
ZnonYZd2jgEbnLr89mYgJ4Dx0 |
10 |
|
This document details an acute toxicity test of a mixture containing perfluorooctanesulfonate (PFOS) conducted on Daphnia magna, using a sample produced by 3M in Antwerp, Belgium, and outlines the test conditions and methodology according to OECD Guideline 202.
|
1995 |
AR226-0894
|
3QnQZwd7qJQv1knL6pmr9g3BD |
9 |
|
The document reports on an acute toxicity test of a mixture containing perfluorooctanesulfonate (PFOS) conducted on fathead minnows (Pimephales promelas) according to OECD Guideline 203, with details on the test conditions and methodology used to determine toxicity.
|
1995 |
AR226-0905
|
dDx4Lr9VMo8bpVbpRZEpBJoKQ |
11 |
|
The document details an acute toxicity test of a mixture containing perfluorooctanesulfonate (PFOS) on Daphnia magna, conducted under OECD guidelines, with specific conditions and concentrations outlined, although the results are not statistically applicable due to the nature of the study.
|
1995 |
AR226-0906
|
kDG023p7vgeyzB8wVdakavrzD |
3 |
|
The document details a Microbios Microtox toxicity test conducted on a mixture containing Perfluorooctanesulfonate (PFOS) to assess its acute toxicity using the Photobacterium phosphoreum species, with results indicating various nominal concentrations for evaluation.
|
1995 |
AR226-0907
|
REdaNNQ0adnnM4wrYpev2Gwz |
13 |
|
The document details an Activated Sludge Respiration Inhibition Test conducted on a mixture containing Perfluorooctanesulfonate (PFOS) to assess its impact on respiration rates in activated sludge, using a method based on OECD Guideline 209.
|
1995 |
AR226-0908
|
ZBEKQw3nqV9n8dvJBovMKq4aL |
10 |
|
The document details the ion spray LC/MS determination of perfluoro analytical standards provided by 3M Medical Department, prepared by Advanced BioAnalytical Services, Inc. for toxicology studies.
|
1995 |
AR226-0330
|
VJvYGBv76oNm7am6xE6njBYmw |
60 |
|
The document reports on a biodegradation study of the perfluorinated compound 2-(N-Ethylperfluorooctanesulfonamido)ethyl acrylate (CAS # 423-825), indicating low biodegradability results of 4%, 1%, and 6% across three replicates, while raising concerns about the purity and methodology used in the testing process
|
1995 |
AR226-0412
|
bmjxxok3GJQxN5Y7yZMvJ4QD |
35 |
|
The document is a final report on an acute dermal toxicity study of T-6342, sponsored by 3M and conducted by Corning Hazleton Inc. in accordance with OECD guidelines, completed on October 24, 1995.
|
1995 |
AR226-0427
|
85Xp870vvx96Ee2QRnr3p8z1a |
32 |
|
The document is a final report on a mutagenicity test of T-6342 conducted by Corning Hazleton for 3M Corporation, which involved an in vivo mouse micronucleus assay to assess the potential mutagenic effects of the substance.
|
1995 |
AR226-0435
|
a4pma8knD6mxoENYBELXYZYBX |
23 |
|
The document is a final report on a mutagenicity test of a substance identified as T-6342 conducted by Corning Hazleton for 3M Corporation, using the Salmonella - Escherichia coli/mammalian-microsome reverse mutation assay, confirming compliance with Good Laboratory Practice regulations.
|
1995 |
AR226-0436
|
mBNDgBng77m1gnvn7VEmnzgO |
30 |
|
The document details a bioconcentration test of perfluorooctanoic acid ammonium salt (PFOA ammonium salt) conducted on fathead minnows to analyze fluoride levels, using a method developed by 3M, although the purity of the test sample was not fully characterized.
|
1995 |
AR226-0496
|
91BZ4xLpGkGvBbznqEM77vBEe |
24 |
|
The document details a toxicity study on Perfluorooctanoic acid (PFOA) conducted in 1995, assessing its effects on the aquatic plant species Selenastrum capricornutum using U.S. EPA guidelines, with findings reported in 1996.
|
1995 |
AR226-0518
|
JJKbkBe6K3dKnYEYo3wDErewr |
28 |
|
The document details an acute toxicity study of Perfluorooctanoic acid (PFOA) conducted in 1995-1996 on the fish species Pimephales promelas, using a test substance with a purity of 96.5-100% PFOA, to determine its lethal concentration (LC50) under controlled laboratory conditions.
|
1995 |
AR226-0519
|
rQrorpMbYD24bEq23dvKVvM7 |
29 |
|
The document details a study on the acute toxicity of Perfluorooctanoic acid (PFOA) to the aquatic invertebrate Daphnia magna, conducted under U.S. EPA-TSCA guidelines, with a focus on determining LC50 and EC50 values over a 48-hour exposure period.
|
1995 |
AR226-0520
|
qdJQKyOa0NDzEKXQNKQZ8gXEK |
29 |
|
The document is a final report on the analysis of T-5877 in a cell proliferation assay conducted on rat liver cells, submitted to 3M Corporation by Hazleton Washington, Inc., confirming compliance with Good Laboratory Practice regulations and the integrity of the study results.
|
1994 |
AR226-0270
|
LgbBKxNQDyOQqmXM5Mqp3n3xQ |
53 |
|
The document reports on a failed biodegradation study of Perfluorooctanesulfonate, Lithium salt (PFOS Li salt), conducted by Pace Laboratories for 3M Company, which could not produce usable carbonaceous BOD data after multiple attempts due to potential toxicity or lack of demand from the sample.
|
1994 |
AR226-0058
|
M23BRMgddR7o5rX77rr9Mzna |
4 |
|
The document details an acute toxicity test conducted on fish (Pimephales promelas) using a test sample of Perfluorooctanesulfonate, Lithium salt (PFOS Li salt) from a 3M production lot, with a focus on determining the LC50 values over a 96-hour exposure period.
|
1994 |
AR226-0111
|
4aw1B0nvDmdEDOaJNkmYODV1R |
9 |
|
The document reports on an acute toxicity study of Perfluorooctanesulfonate (PFOS Li salt) on the aquatic invertebrate Daphnia magna, finding a 48-hour EC50 value of 210 mg/L.
|
1994 |
AR226-0112
|
g2Qdx4NjKqoNpnbLgXoM2g4Z3 |
7 |
|
The document reports the results of a Microtox toxicity test conducted on a mixture of perfluorooctanesulfonate lithium salt (PFOS Li salt) in water, indicating an EC10 value of 564 mg/L and an EC50 value greater than 1000 mg/L for Photobacterium phosphoreum after 15 minutes of exposure.
|
1994 |
AR226-0113
|
aJXdrMgXN0G557NrE41nZvyrN |
12 |
|
The document details an Activated Sludge Respiration Inhibition Test conducted on Perfluorooctanesulfonate, Lithium salt (PFOS Li salt), indicating that the test solutions exhibited low dissolved oxygen levels during the experiment, which may have affected the results.
|
1994 |
AR226-0114
|
VjOaMroed3Jqny9BnyLDOY13w |
12 |
|
This document reports on a biodegradation study of a mixture containing 0.5% perfluorooctanesulfonate (PFOS) conducted by Pace, Inc. for 3M Company, highlighting significant Chemical Oxygen Demand (COD) and Biochemical Oxygen Demand (BOD) values while noting the study's lack of methodological clarity and sample purity characterization.
|
1994 |
AR226-0862
|
MEkKnOe22eMJ4B6e3vpovRa9 |
6 |
|
The document reports on an acute toxicity test of a mixture containing 0.5% PFOS, conducted on fathead minnows (Pimephales promelas) using OECD Guideline 203, with results indicating the need for caution due to the presence of impurities in the test sample.
|
1994 |
AR226-0863
|
OzbNJ0g4ypDLon1myMEQME6Nv |
6 |
|
The document reports on an acute toxicity test of a mixture containing 0.5% PFOS (perfluorooctanesulfonate) conducted on Daphnia magna, detailing the test conditions and methodology used in the study.
|
1994 |
AR226-0865
|
KzXQgRMN6KyQap4QoNLwnGxx6 |
4 |
|
The document details a Microtox toxicity test conducted on a mixture containing 0.5% perfluorooctanesulfonate (PFOS) produced by 3M, indicating that the test sample, FC603F, may have incompletely characterized concentrations of impurities affecting the toxicity data.
|
1994 |
AR226-0866
|
1bYxYMO4J72eY41jNbwxMDMK |
13 |
|
The document details an activated sludge respiration inhibition test conducted on a mixture containing 0.5% PFOS, produced by 3M, to evaluate its toxicity using OECD Guideline 209, with results indicating potential inaccuracies due to impurities in the test sample.
|
1994 |
AR226-0867
|
5OdLLoJZXpBQ50wDda8JynVz |
10 |
|
The document reports on the evaluation of the mutagenic activity of T-5874 using the Ames Salmonella/microsome test, conducted by NOTOX B.V. in compliance with GLP standards.
|
1994 |
AR226-0297
|
Lg6zw7e1VqeD1pw2pQRwe5D8w |
24 |
|
The document reports on a study conducted by NOTOX evaluating the ability of the substance T-5874 to induce chromosome aberrations in cultured peripheral human lymphocytes, adhering to Good Laboratory Practice standards.
|
1994 |
AR226-0298
|
jB05LEY5aJye6eap5qeL5wwBy |
27 |
|
The document reports on the evaluation of the mutagenic activity of T-5874 in an in vitro mammalian cell gene mutation test using L5178Y mouse lymphoma cells, conducted by NOTOX in compliance with GLP standards.
|
1994 |
AR226-0299
|
M497bJOOEZ674aKQrvXQmwQDy |
23 |
|
The document is a final report on the analysis of T-5794 in a cell proliferation assay using rat liver cells, conducted by Hazleton Washington, Inc. for 3M Corporation, confirming compliance with Good Laboratory Practice regulations.
|
1994 |
AR226-0302
|
JKnB4r6bwb618LRmp9wN4Xae |
37 |
|
The document is a final report on the analysis of T-5878 in a cell proliferation assay using rat liver cells, conducted by Hazleton Washington, Inc. for 3M Corporation, with findings compliant with Good Laboratory Practice regulations.
|
1994 |
AR226-0303
|
2jDEEdYDRzJGOJvj7nGo5RxL5 |
50 |
|
The document reports on a study conducted by NOTOX B.V. to evaluate the ability of the substance T-5869, sponsored by 3M Belgium, to induce chromosome aberrations in cultured peripheral human lymphocytes, adhering to Good Laboratory Practice standards.
|
1994 |
AR226-0318
|
8OzzNqVyO2exLrB90BOjDGQrK |
26 |
|
The document reports on a fluorochemical exposure assessment of 3M Decatur chemical and film plant employees, revealing a geometric mean serum PFOS level of 0.944 ppm among chemical plant workers and 0.136 ppm among film plant workers, with the highest PFOS level recorded at 10.600 ppm, and indicates that the findings will inform an updated retrospective cohort mortality study.
|
1994 |
AR226-0950
|
LJNoymdpvkML70m0nNq7ovq2z |
406 |
|
This document reports the results of a study conducted by 3M Company to estimate the log Pow (partition coefficient) for N-ethylperfluorooctane sulfonamidoethanol (N-EtFOSE alcohol), finding values of 5.6 and 4.4 for different peaks.
|
1994 |
AR226-0379
|
RYxz7dw3x4V28drMZDM22rbk |
17 |
|
The document reports on the physical and chemical properties of the perfluorinated compound 2-(N-Ethylperfluorooctanesulfonamido)ethyl acrylate (also known as D-1), indicating a water solubility of 0.89 mg/L and varying hydrolysis rates at different pH levels, while noting that the purity and identity of the substance
|
1994 |
AR226-0973
|
X8rY0jBgBg5EX37m903nezjOx |
63 |
|
This is a research article discussing the prevention of fluvastatin-induced toxicity, mortality, and cardiac myopathy in pregnant rats through mevalonic acid supplementation, highlighting significant adverse effects observed at certain dosages of fluvastatin.
|
1994 |
AR226-0559
|
3eBvjeeL1wp2qB3mneoqm7BdJ |
8 |
|
This letter from DuPont to First Brands discusses the potential risks associated with using Teflon K-20, which contains <0.2% ammonium perfluorooctanoate (APFO), as a dedusting agent in cat litter, highlighting the need to consider the safety of employees, cats, and cat owners.
|
1994 |
AR226-1662
|
3eLXjDG4BaL9gywQJB916bZOE |
3 |
|
The memorandum discusses the interest in incorporating micro powders into shaving gel products, specifically addressing concerns about the elimination rate of C-8 (likely referring to PFOA) from the body and the feasibility of this approach.
|
1994 |
AR226-1663
|
3JwXxvdrpxzjoMBMDLYEzZGZ0 |
2 |
|
This document outlines a method developed by 3M for the determination of N-Ethyl Perfluorooctanesulfonamide in air using silica gel sampling tubes and gas chromatography.
|
1993 |
AR226-0241
|
4v0EOp706b1MwJZdVzrNJe3Ra |
2 |
|
The document is a final report on a mutagenicity test for T-5710 conducted in an in vivo rat micronucleus assay, submitted to 3M Corporation by Hazleton Washington, Inc., indicating compliance with EPA FIFRA Good Laboratory Practice Standards.
|
1993 |
AR226-0250
|
44rVzK37VeGV037B6MYG5n7gG |
26 |
|
The document is a final report on a genotoxicity test of T-5710.1, conducted by Hazleton Washington, Inc. for 3M Corporation, which assessed unscheduled DNA synthesis and cell proliferation in rat liver cells, ensuring compliance with Good Laboratory Practice regulations.
|
1993 |
AR226-0251
|
Vjre9oGL853k0RzkEOaNdKGZN |
32 |
|
The document outlines a research protocol by 3M to analyze inpatient and outpatient claims data from Decatur chemical and film plant employees between 1993 and 1998, aiming to compare observed claims events to expected numbers while accounting for age and gender, with a focus on the potential health impacts of exposure to perfluorinated compounds.
|
1993 |
AR226-0022
|
om8ZzDKbZymZ6ZkZgOv1n0oY8 |
19 |
|
The document presents a biodegradation study of a mixture containing perfluorooctanesulfonate (PFOS) produced by 3M, indicating that while the majority of the product components are readily biodegradable, no reliable conclusions can be drawn due to insufficient characterization of the sample and methodology.
|
1993 |
AR226-0701
|
6bdw5yKJ8beJOxnY5zbkVJbEg |
13 |
|
The document reports on a microbial inhibition test evaluating the dehydrogenase activity of a mixture containing 3.0% PFOS (perfluorooctanesulfonate) produced by 3M Company, indicating that the test results are inconclusive due to incomplete characterization of the sample and lack of detailed methodology.
|
1993 |
AR226-0705
|
evEJmK0NVrgjg4dwV7N46maXe |
14 |
|
The document reports on an acute toxicity test conducted on fish using a mixture containing 3.0% PFOS (perfluorooctanesulfonate) as part of the test substance FC-201F, with a 48-hour no observed effect concentration (NOEC) determined to be 500 ppm.
|
1993 |
AR226-0706
|
evNyYGGgm17NExwYb7zVNweBp |
14 |
|
The document reports on a toxicity test of a mixture containing 1.30% PFOS, conducted on the aquatic plant species Scenedesmus subspicatus, revealing a 72-hour EC50 value of 65 mL/L based on nominal concentrations.
|
1993 |
AR226-0850
|
gDEb7BN33joRBN2oxbNbRjqba |
10 |
|
The document is a final report on a mutagenicity test of T-5711 conducted by Hazleton Washington, Inc. for 3M Corporation, using an in vivo rat micronucleus assay to comply with U.S. EPA FIFRA guidelines.
|
1993 |
AR226-0296
|
EmqLyBd46N6N7rRmb5r9OYV1L |
41 |
|
The document is a final report on a genotoxicity test of T-5711.1 conducted by Hazleton Washington, Inc. for 3M Corporation, which involved in vivo/in vitro assays in rat liver cells to assess DNA synthesis and cell proliferation.
|
1993 |
AR226-0295
|
8VOyXR5VBgdzd6vexJx0oGDLm |
46 |
|
The document details a manometric respirometry test conducted in 1993 to assess the biodegradability of a mixture containing 6% PFOS, indicating that the data may not accurately reflect the biodegradability of the fluorochemical component due to incompletely characterized concentrations of impurities.
|
1993 |
AR226-0899
|
nmg59Qd99z54bbJoro5VXMY6G |
10 |